The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...

The researchers found that individual SGLT-2 inhibitors showed similar cardiovascular effectiveness at clinically effective ...

Nearly half of patients with advanced ovarian cancer treated with first-line poly-ADP-ribose polymerase (PARP) inhibitors experienced recurrence in this real-world study, emphasizing the need for ...

PhD Defense of W.P.J. Cox (UMC Utrecht/Kinderen) ...

Safety: Aspirin was well-tolerated, with no major safety concerns reported. The ASCOLT trial showed that aspirin did not ...

Phosphoproteomics unveils the mode of action of clinical ATR inhibitors and explains their synergy with Gemcitabine in ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

6, and PEOPLE has an exclusive look at the trailer Laverne Cox is making her mark in Prime Video's new comedy, Clean Slate. In PEOPLE's first look at the heartfelt series, Cox, 52, takes on the ...